Literature DB >> 7556232

Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Helicobacter pylori Serology Study Group.

R A Feldman1, J J Deeks, S J Evans.   

Abstract

The performance of eight commercially available EIA kits in detecting antibody to Helicobacter pylori was evaluated by a panel of 17 laboratories using serum from 59 patients selected from endoscopy clinics in Belgium, Ireland, Italy, the Netherlands and Switzerland. Each laboratory received a randomly numbered set of sera and was ignorant of the culture results of the patients. The performance of the kits was assessed in terms of diagnostic accuracy compared to culture (measured by sensitivity and specificity), the inter-laboratory variability in diagnostic accuracy and the number of laboratories that experienced problems in using the kits. Grey zone results, which are routinely used to highlight the uncertain interpretation of results that lie near the cut-off point between positive and negative diagnoses, were accounted for in the analysis. Laboratories experienced practical problems in using some kits, whilst other kits were found to have high inter-laboratory variation or low diagnostic accuracy. There was no single kit that performed better on every criterion than the others. The Orion kit was a good all-round performer, whilst the Roche kit was excellent at detecting positive results, although it had a slightly raised false-positive rate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556232     DOI: 10.1007/bf02114899

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

2.  Comparison of ELISA antigen preparations alone or in combination for serodiagnosing Helicobacter pylori infections.

Authors:  A M Hirschl; B J Rathbone; J I Wyatt; J Berger; M L Rotter
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

3.  [Follow-up of the quantitative serological response to the treatment of Helicobacter pylori infection in children].

Authors:  M López-Brea; E Martín; T Alarcón; M D Acuña; M Gimeno; J C Sanz
Journal:  Enferm Infecc Microbiol Clin       Date:  1993-01       Impact factor: 1.731

4.  Diagnostic tests for Helicobacter pylori: comparison and influence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; P Boothman; I Nakshabendi; J Reid; C Morran; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

5.  Diagnosis of Helicobacter pylori infection in adults and children by using the Malakit Helicobacter pylori, a commercially available enzyme-linked immunosorbent assay.

Authors:  U Blecker; S Lanciers; B Hauser; Y Vandenplas
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

6.  Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies.

Authors:  C Granberg; A Mansikka; O P Lehtonen; H Kujari; R Grönfors; H Nurmi; I Räihä; M R Ståhlberg; R Leino
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

7.  A sensitive and specific serologic test for detection of Campylobacter pylori infection.

Authors:  D J Evans; D G Evans; D Y Graham; P D Klein
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

8.  Diagnosis of Helicobacter pylori infection in adult and pediatric patients by using Pyloriset, a rapid latex agglutination test.

Authors:  T U Westblom; E Madan; S Gudipati; B R Midkiff; S J Czinn
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

9.  [Helicobacter detected in children of Helicobacter pylori-positive parents].

Authors:  G Rákóczy; G Márk; A Takács; A Szentmihályi; A Joós
Journal:  Orv Hetil       Date:  1993-01-31       Impact factor: 0.540

10.  Cell surface proteins of Helicobacter pylori as antigens in an ELISA and a comparison with three commercial ELISA.

Authors:  J Lelwala-Guruge; I Nilsson; A Ljungh; T Wadström
Journal:  Scand J Infect Dis       Date:  1992
View more
  32 in total

1.  Non-invasive testing for Helicobacter pylori.

Authors:  M A Stone
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

Review 2.  Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.

Authors: 
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  Validation of serological tests for Helicobacter pylori infection in an Irish population.

Authors:  N P Breslin; J M Lee; M J Buckley; E Balbirnie; D Rice; C A O'Morain
Journal:  Ir J Med Sci       Date:  2000 Jul-Sep       Impact factor: 1.568

4.  Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations?

Authors:  S Niemelä; T Karttunen; T Korhonen; E Läärä; R Karttunen; M Ikäheimo; Y A Kesäniemi
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

5.  Age-dependent accuracy of Helicobacter pylori antibody assays for adults, with special emphasis on atrophic gastritis.

Authors:  A Salomaa-Räsänen; T U Kosunen; J Mattila; S Sarna; H Rautelin
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 6.  Diagnosis of Helicobacter pylori infection : A short review.

Authors:  Ante Tonkic; Jonatan Vukovic; Pavle Vrebalov Cindro; Valdi Pesutic Pisac; Marija Tonkic
Journal:  Wien Klin Wochenschr       Date:  2018-06-29       Impact factor: 1.704

Review 7.  New immunological assays for the diagnosis of Helicobacter pylori infection.

Authors:  D Vaira; J Holton; M Menegatti; C Ricci; F Landi; A Ali'; L Gatta; C Acciardi; S Farinelli; M Crosatti; S Berardi; M Miglioli
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

8.  Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals.

Authors:  H J Windle; Y S Ang; V Athie-Morales; V A Morales; R McManus; D Kelleher
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

9.  Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes.

Authors:  S Rosenstock; L Kay; C Rosenstock; L P Andersen; O Bonnevie; T Jørgensen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

10.  Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?

Authors:  Akira Babazono; Motonobu Miyazaki; Hiroshi Une; Eiji Yamamoto; Toshihide Tsuda; Yoshio Mino; Alan L Hillman
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.